Description

3-Quinolinecarboxylic Acid, 1-Cyclopropyl-7-[4-(Dithiocarboxy)-1-Piperazinyl]-6-Fluoro-1,4-Dihydro-4-Oxo-, Disodium Salt (9Ci) is a high-purity, complex heterocyclic compound designed for advanced research and pharmaceutical development. This compound is critical for medicinal chemistry applications, particularly as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories, biotechnology firms, and academic research institutions focused on developing new antibacterial or targeted drug candidates.

Application

• Pharmaceutical Intermediate: Serves as a crucial building block in the synthesis of novel quinolone-based antibiotics and other therapeutic agents.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for drug discovery programs targeting bacterial infections.
• Active Pharmaceutical Ingredient (API) Development: Investigated as a potential core structure for new API candidates due to its complex, functionalized quinoline scaffold.
• Biochemical Research: Employed as a tool compound in enzymatic and receptor-binding assays to study biological pathways.
• Process Chemistry & Scale-Up: Used in the development and optimization of scalable synthetic routes for complex molecules in pilot plants.
• Reference Standard: Acts as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.

Basic Information

Item	Details
Product Name	3-Quinolinecarboxylic Acid, 1-Cyclopropyl-7-[4-(Dithiocarboxy)-1-Piperazinyl]-6-Fluoro-1,4-Dihydro-4-Oxo-, Disodium Salt (9Ci)
CAS No.	1081979-64-7
Molecular Formula	C17H15FN4Na2O3S2
Molecular Weight	460.43 g/mol
Synonyms	1-Cyclopropyl-7-[4-(dithiocarboxy)-1-piperazinyl]-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid disodium salt; Disodium 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-sulfanylcarbothioylpiperazin-1-yl)quinoline-3-carboxylate; 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)quinoline-3-carboxylic acid derivative; GSK-1 Inhibitor Intermediate; Quinolone-carboxylate disodium salt; Antibacterial research compound 1081979-64-7.
EINECS	Contact for details

Quality Control

Our 3-Quinolinecarboxylic Acid derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and tests for residual solvents and heavy metals, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 2.0%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	≤ 20 ppm
Assay (on dried basis)	97.0% - 102.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.